The cell-free medium obtained after 48 hour culture of phytohemagglutinin (PHA)-stimulated leukocytes of three cystic fibrosis (GF) subjects and two carriers, contained a ciliary dyskinesia factor (CDF) detected by a modified rabbit tracheal bioassay. Positive CDF responses began to be observed in supernates of parallel non-stimulated cultures of leukocytes from these same CF affected and carrier individuals by 72 hours of culture. Cell-free media from leukocyte cultures of four normal donors did not produce a positive CDF response with or without PHA over a period of 6 days.
The cell-free medium of long-term lymphoid lines derived from three CF affected and four CF carrier subjects demonstrated a positive CDF response, while media from similar lymphoid lines derived from normal subjects contained no CDF. Distinction between homozygous and heterozygous lymphoid lines was not always possible, although there was a tendency of the homozygous lines to give an earlier CDF response than the heterozygous ones. Addition of rabbit anti-human IgG to the CDF positive cell line supernates resulted in the elimination of their ability to elicit a positive CDF response in each instance.
Speculation
CDF is a manifestation of a normal cellular product which is a small molecule bound to IgG. The resulting complex represents the CDF detected by bioassay. The defect in CF is in the production or release of a factor inhibiting the CDF.
INTRODUCTION
Human lymphocytes treated with PHA undergo morphologic transformation and increased protein synthesis, followed by mitosis (21,1). Concomitant with these phenomena are increases in the total activity of several lysosomal enzymes (14, 19) , as well as some non-lysosomal enzymes (19, 24) . Measurement of enzyme activity during stimulation of lymphocytes with PHA has provided a means of detecting inborn errors of metabolism and the identification of heterozygotes. Normals, heterozygotes, and homozygotes have been clearly delineated in both Pompe's disease (deficiency of acid alpha-1, 4-glucosidase) (15) and familial lysosomal acid phosphatase disorder (20).
In addition, distinction between normals and homozygotes for homocystinuria (cystathionine synthase deficiency) has also been demonstrated (13).
Lymphoid cell lines derived from human peripheral blood have been established in permanent suspension culture (11) from individuals with varied benign (12) and malignant (7, 17) lymphoproliferative disorders, as well as normal subjects (5, 10, 18) . In one of these papers (5), the establishment of such lines from CF carriers has been reported. The technique for establishing lymphoid lines was improved in our laboratory by using a combination of PHA stimulation and incubation with Epstein-Barr virus (2) .
We have previously demonstrated the relative stability of the diploid chromosomal pattern of the lymphoid lines, as well as a similarity of donor cells and lymphoid cell lines in the synthesis of a variety of enzymes including the maintenance of their genetic polymorphisms (8) . Lymphoid line cells, derived from subjects with Chediak-Higashi syndrome retain the unusual morphologic features observed in the donor (4) . Also, lymphoid lines derived from subjects with inborn errors, such as the Lesch-Nykan syndrome (6) , and rnetachromatic leukodystrophy (MLD) (3) have reflected the enzyme deficiencies characteristic of the cell line donors.
In this paper, we are reporting the production of a ciliary dyskinesia factor (CDF), resembling in its action the serum factor described by Spock (23), by peripheral leukocytes from homozygotes and obligate heterozygotes for CF, and by long-term lymphoid cell lines established from CF affected and carrier subjects.
MATERIALS AND METHODS
Peripheral leukocyte culture. Heparinized peripheral blood was obtained from three patients with CF, two obligate heterozygotes, and four healthy donors. In all cases, blood was allowed to sediment by gravity in a syringe until just prior to buffy coat formation. The supernatant plasma rich in white cells was removed through a bent needle and centrifuged at 150 XG for 15 minutes. The isolated leukocytes were washed once with the culture medium, re-centrifuged, and then re-suspended in medium. Lymphocytes in each sample were differentially counted in a hemocytometer, but no attempt was made to isolate purified lymphocytes.
Each culture tube contained 1 x 10^ lymphocytes in 1 ml of RPMI-1640 medium, supplemented with 10% fetal calf serum, L-glutamine, penicillin and streptomycin. Two series of tubes were prepared from each subject.
In one series 2 ug/ml of purified PHA, MR68 or 69 (Burroughs-Wellcome), was added, while the other series contained no PHA. All cultures were maintained at 37°C, and gassed with 5% CO2. Replicate cultures of both series from each patient were stopped after 24, 48, and 72 hours, and Cell lines were allowed to reach a stable population of 1-2 x 10" cells per ml of culture fluid and 5 ml aliquots of this cell suspension were centrifuged at 150XG for 15 minutes. The cell pellet was washed once with medium, re-centrifuged and the pellet was resuspended in 10 ml of the culture medium.
The cells were cultured in 25 sq. cm. tissue-culture plastic flasks (Falcon Plastics) for 48 hours at 37°C in the presence of 5% CC* 2 . Subsequently the cells were removed by centrifugation and the supernate was collected for bioassay. Duplicate cell counts were performed in the heterozygous and homozygous CF lines, and cultures with cell concentrations of 0.5 x 10 cells per ml of medium were prepared. The cell free media from these cultures were tested for CDF activity after 40, 48, and 66 hours of culture.
Each of the cell-free supernates of the CF and carrier lymphoid cell lines was treated with rabbit-anti-human-IgG (Meloy Laboratories, ^gmg/ml initial concentration) in the following manner: 0.9 ml of each supernate + 0.1 ml rabbit anti-human-IgG were incubated at 37°C for one hour, and then overnight at 4"C, centrifuged to remove antigen-antibody complexes, and the resulting supernates were tested for CDF activity by the trachea! bioassay.
Bioassay. The cell-free medium of each culture was assessed for cilioinhibitory properties by using our modification (9) of the Spock bioassay system (23) which utilizes ciliated rabbit tracheal explants. The preliminary screening of tracheal explants, as well as all bioassay microscopy was performed in a 37"C warm room. An appropriate border of a ciliated explant was brought into focus within 15 to 30 seconds after the sample to be evaluated was placed on the tracheal tissue on a glass slide, and the ciliary reaction was then observed and recorded after three minutes. The reaction
•was allowed to proceed an additional three minutes, and the results again recorded at six minutes. Samples were assayed individually on at least two separate occasions, being alternately unknown to one of two observers. The time intervals used have been found to be adequate for the detection of the Spock factor in sera of CF patients and obligate heterozygotes (9) .
RESULTS
Peripheral leukocytes. Results of the bioassays performed on the cell-free media of the short term peripheral leukocyte cultures are recorded in Table I .
The findings indicate that the FHA-stimulated and non-stimulated leukocytes of normal donors do not produce detectable CDF during the entire culture interval used. However, the PHA-stimulated leukocytes of patients and heterozygotes with CF seem to produce by 48 hours of culture a factor (s) causing ciliary dyskinesia. The ciliary dyskinesia effects began to be observed in non-stimulated cultures from CF homo-and heterozygotes by 72 hours.
Lymphoid cell lines.
Results of the bioassays performed on the cell-free media of the established lymphoid cell lines are presented in Table II . 
DISCUSSION
The data from the short term leukocyte cultures suggest that PHA stimulates the lymphocytes of CF patients and heterozygotes to produce or release CDF. The production of CDF by non-stimulated cells in longer culture periods probably reflects the "spontaneous" activation of cultured lymphocytes sometimes observed after three days of culture in the presence of fetal calf serum, or a slower rate of production or release by non-stimulated cells.
Moreover, these data indicate that the leukocytes can produce CDF, which is considered characteristic of serum from CF patients and carriers.
Another similarity to the studies with serum CDF is that it was not possible to distinguish CF homozygotes from heterozygotes. It has previously been reported by McCombs and Bowman (16) and Schmoyer, et al. (22) , that a substance of molecular weight 60, 000 to 150, 000, not dissociable from IgG by separative techniques, contains the CDF activity in serum.
Since in our studies, rabbit anti-human-IgG treated samples effectively lost their CDF activity, and since both the long and short-term data reported here involve immunoglobulin producing cells, it is likely that the CDF characteristic of CF sera, peripheral leukocytes, and long-term lymphoid lines is a fraction 
